Skip to main content

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • Critical Care

    When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one.

  • Hospital Care

    From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain or maintain your health.

  • Renal Care

    Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs.

  • Surgical Care

    We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery.

Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals
  • Critical Care

    Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the ICU.

  • Hospital Care

    From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital.

  • Nutritional Care

    Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally.

  • Renal Care

    Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients.

  • Surgical Care

    Delivering innovative surgical products that help you operate with confidence, precision and speed.

  • Our Products

    Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For more than 85-years, we have worked at the intersection of saving and sustaining lives.

Perspectives
  • CEO Insights

    Joe Almeida shares his outlook on a range of topics.

  • Patients' Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Healthcare Insights

    We’re engaging with industry thought leaders to explore how science and innovation advance healthcare.

  • Community Engagement

    Enriching the communities where we live and work.

Our Story

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Leadership

    Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere.

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For more than 85 years, we’ve been focused on saving and sustaining lives and elevating patient care.

Investors

Our objective is to accelerate growth by expanding Baxter’s impact across the healthcare spectrum supported by the evolution of our new product pipeline.

Investors
  • Investor Overview

    Information regarding Baxter’s recent announcements, upcoming & past events, and other useful resources for investors.

  • Annual Reports & Proxy

    Baxter's Annual Chairman Letter, Proxy Statement and Form 10-K filings sorted by year.

  • Financial Schedules

    Financial schedules and Non-GAAP reconciliations by quarter.

  • SEC Filings

    All Forms filed with the U.S. Securities and Exchange Commission sorted by year.

  • Events & News

    Upcoming, featured, and past events and presentations. Also read the latest news on Baxter innovations and initiatives, and follow us on our corporate social media channels.

  • Stock Information

    Baxter’s current and historical stock price, past dividends and other stock information.

  • ESG & Corporate Responsibility

     

  • Resources & FAQs

    Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions.
Home  >  Investors  >  ESG & Corporate Responsibility  >  2021 SASB Index

2021 SASB Index

2021 SASB Index

This index includes and references information related to the Sustainability Accounting Standards Board (SASB) Medical Equipment and Supplies Sustainability Accounting Standard. Data are calendar year 2021, unless stated otherwise, and do not include Hillrom.

For more information about corporate responsibility at Baxter, including our commitment and goals, performance data, materiality assessment and Global Reporting Initiative (GRI) Content Index, please visit our 2021 Corporate Responsibility Report.

Medical Equipment and Supplies

Affordability & Pricing Product Safety Ethical Marketing Product Design & Lifecycle Management Supply Chain Management Business Ethics

Affordability & Pricing

SASB Index Table
Code SASB Metric 2021 Reporting
HC-MS-240a.1 Ratio of weighted average rate of net price increases (for all products) to the annual increase in the U.S. Consumer Price Index Baxter does not disclose this data. See Contractual Arrangements in Baxter’s 2021 Annual Report on Form 10-K for information about some factors that impact product pricing.
HC-MS-240a.2 Description of how price information for each product is disclosed to customers or to their agents Baxter products are sold through contracts with customers, both within and outside the United States. Some of these contracts have terms of more than one year and place limits on our ability to increase prices; some contracts also specify minimum quantities to be purchased by the customer; and some contracts may include variable consideration related to rebates, sales discounts and/or wholesaler chargebacks. Our customers include hospitals, governments, kidney dialysis centers and other organizations. Both in the United States and outside, hospitals and other customers have joined purchasing entities, such as group purchasing organizations, integrated delivery networks and public contracting authorities, to enhance purchasing power.

See the Contractual Arrangements, Competition and Healthcare Cost Containment, and Revenue Recognition sections in Baxter's 2021 Annual Report on Form 10-K.
back to top

Product Safety

SASB Index Table
Code SASB Metric 2021 Reporting
HC-MS-250a.1 Number of recalls issued, total units recalled In 2021, Baxter issued
  • Ten medical device product recalls that were reported to FDA and removed from the market or corrected1
  • Zero medical device product recalls that were not reported to FDA1
  • Sixteen medical device product recalls that were reported to non-U.S. national regulatory authorities and removed from the market or corrected

See Continually Improve Manufacturing Capabilities and Baxter Data Summary in the Baxter 2021 Corporate Responsibility Report for information about the company’s product improvements and recall data, inclusive of drug-related recalls.
HC-MS-250a.2 List of products listed in the FDA’s MedWatch Safety Alerts for Human Medical Products database

As of Dec. 31, 2021, the MedWatch Safety Alerts for Human Medical Products database included the following Baxter medical device products: Dose IQ Safety Software and Spectrum IQ Infusion System.
HC-MS-250a.3 Number of fatalities related to products as reported in the FDA Manufacturer and User Facility Device Experience. Under FDA regulations, manufacturers and device user facilities must report information that reasonably suggests a medical device may have caused or contributed to a fatality or serious injury. Manufacturers must also submit to FDA reports of certain malfunctions. Such reports for Baxter’s medical devices are available here: Manufacturer and User Facility Device Experience
HC-MS-250a.4 Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP), by type In 2021, Baxter received
  • Two Form 483s
  • Zero warning letters
  • Zero seizures
  • Zero consent decrees

See Continually Improve Manufacturing Capabilities in the Baxter 2021 Corporate Responsibility Report, as well as Certain Regulatory Matters in Baxter’s 2021 Annual Report on Form 10-K for related information.

1 Differences compared with data on FDA websites may be due to timeframe (the date Baxter takes an action may differ from the date FDA classifies that action), definition of "recall" (FDA data includes actions taken even if the product is not removed or corrected), and classification by product group vs. product code (FDA counts each impacted product code within a product family as a distinct recall).



back to top

Ethical Marketing

SASB Index Table
Code SASB Metric 2021 Reporting
HC-MS-270a.1 Total amount of monetary losses as a result of legal proceedings associated with false marketing claims In 2021, Baxter had no monetary losses due to legal proceedings associated with false marketing claims that were previously reported in any company Exchange Act filings.
HC-MS-270a.2 Description of code of ethics governing promotion of off-label use of products Off-label promotion is strictly prohibited at Baxter. See the Baxter Code of Conduct and the Baxter Global Interactions Policy. See Ethics and Compliance in the Baxter 2021 Corporate Responsibility Report for information about the company's approach in this area.
back to top

Product Design & Lifecycle Management

SASB Index Table
Code SASB Metric 2021 Reporting
HC-MS-410a.1 Discussion of process to assess and manage environmental and human health considerations associated with chemicals in products, and meet demand for sustainable products See Sustainable Design, Materials Use in Products and Packaging, Materials of Concern and Striving for Full Materials Disclosure in the Baxter 2021 Corporate Responsibility Report for information about the company's approach in this area.
HC-MS-410a.2 Total amount of products accepted for takeback and reused, recycled, or donated, broken down by: (1) devices and equipment and (2) supplies See Product End-of-Life in the Baxter 2021 Corporate Responsibility Report for product recovery data and information about the company's approach in this area.
back to top

Supply Chain Management

SASB Index Table
Code SASB Metric 2021 Reporting
HC-MS-430a.1 Percentage of (1) entity's facilities and (2) Tier I suppliers' facilities participating in third-party audit programs for manufacturing and product quality

Between 2019 and 2021, approximately 40% of Baxter's total facilities worldwide completed third-party audits based on ISO 13485 or ISO 9001 (including through the Medical Device Single Audit Program), approximately 50% completed ministry of health or equivalent audits (depending on location) related to manufacturing and product quality, and nearly 10% completed safety marking (such as CE marking) audits.

As of Dec. 31, 2021, 29% of Baxter's Tier 1 Suppliers had obtained third-party certification. See Continually Improve Manufacturing Capabilities and Supplier Audits in the Baxter 2021 Corporate Responsibility Report for related information.
HC-MS-430a.2 Description of efforts to maintain traceability within the distribution chain Baxter has a range of systems and processes to maintain traceability of materials throughout the product supply and distribution chain:
  • Traceability of materials from suppliers to Baxter, and throughout the manufacturing process, is maintained utilizing electronic systems.
  • Products manufactured by Baxter are labeled with an identifier that is traceable from the manufacturing process to the customer and may utilize barcoding and serialization technology to facilitate electronic track-and-trace capability. Enterprise resource planning (ERP) systems are used to manage traceability to the point of sale. Baxter has business agreements with our wholesalers to ensure traceability is maintained within their distribution chains, and we can access related information if needed.
  • Baxter maintains a range of compliance-focused initiatives to help ensure all products are labeled as required by local and regional regulations to enable traceability.

See section 7.11, Product Identification and Traceability of the Baxter Supplier Quality Standards and Customs Trade Partnership Against Terrorism program content in Industry Collaboration in the Baxter 2021 Corporate Responsibility Report for more information.
HC-MS-430a.3 Description of the management of risks associated with the use of critical materials See Baxter’s Position Statement on Conflict Minerals and our most recent Conflict Minerals Report.
back to top

Business Ethics

SASB Index Table
Code SASB Metric 2021 Reporting
HC-MS-510a.1 Total amount of monetary losses as a result of legal proceedings associated with bribery or corruption In 2021, Baxter had no monetary losses due to legal proceedings associated with bribery or corruption that were previously reported in any company Exchange Act filings. See Ethics and Compliance in the Baxter 2021 Corporate Responsibility Report for information about the company's approach in this area.
HC-MS-510a.2 Description of code of ethics governing interactions with health care professionals

See Baxter’s Global Interactions Policy and Ethics and Compliance in the Baxter 2021 Corporate Responsibility Report for information about the company's approach in this area.

Baxter has adopted the AdvaMed Code of Ethics and also belongs to similar industry and professional associations around the world. See Professional Codes of Ethics and Industry Standards on Baxter's Ethics and Compliance page for information.
back to top

Download SASB Index

Investor Toolkit